Clicky

MaxCyte, Inc.(MXCT) News

Date Title
Mar 13 MaxCyte's (LON:MXCT) investors will be pleased with their notable 68% return over the last five years
Mar 13 11 Oversold Healthcare Stocks To Buy Right Now
Mar 12 MaxCyte Inc (MXCT) Reports Mixed Financial Results for Q4 and Full Year 2023
Mar 12 MaxCyte Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance
Mar 4 MaxCyte Initiates Full Year 2024 Guidance and Reaffirms 2023 Preliminary Results
Jan 23 MaxCyte Signs Strategic Platform License with Imugene to Advance their Cancer Immunotherapy Programs
Jan 2 MaxCyte Confirms Appointment of Maher Masoud as President, Chief Executive Officer and Director
Dec 19 Hedge Funds Say These Penny Stocks Are Poised to Explode
Dec 7 Insider Sell Alert: President and CEO Douglas Doerfler Sells 124,450 Shares of MaxCyte Inc (MXCT)
Dec 2 Insider Sell Alert: President and CEO Douglas Doerfler Sells 25,550 Shares of MaxCyte Inc (MXCT)
Sep 6 MaxCyte Appoints Ali Soleymannezhad as Executive Vice President of Bioprocessing
Sep 5 MaxCyte to Participate in Baird Global Healthcare Conference
Apr 28 MaxCyte, Inc. (LON:MXCT) insider upped their holding by 400% earlier this year